These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 145666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M, Kashiwagi S, Pei W, Fujisawa H, Ito H, Nakamura K.
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antifibrinolytic effect of heparin].
    Rozenfel'd MA, Leonova VB, Khavkina LS, Meshkov BB.
    Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
    [Abstract] [Full Text] [Related]

  • 12. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B, Francis CW, Marder VJ.
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW, Marder VJ.
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
    Plow EF, Gramse M, Havemann K.
    J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
    [Abstract] [Full Text] [Related]

  • 17. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
    Gramse M, Bingenheimer C, Schmidt W, Egbring R, Havemann K.
    J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA, Dempfle CE, Matsuda M, Heene DL.
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.